Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Novotech Recognized as Top 10 CRO in CenterWatch Site Relationship Benchmarking Report 2022-02-04 19:47
Vitro S.A. sells Cytognos to BD to prioritize the market launch of their new and disruptive Molecular Biology and Anatomic Pathology diagnostic platforms 2022-02-04 17:23
Nanoform signs GMP manufacturing program with TargTex following formulation success 2022-02-04 15:54
New Zealand's Medsafe Grants Provisional Approval for Novavax' COVID-19 Vaccine 2022-02-04 06:54
LISCure Biosciences Announces Research Collaboration with The Scripps Research Institute for Immuno-Oncology 2022-02-03 22:00
Medicines and Healthcare Products Regulatory Agency Grants Conditional Marketing Authorization for Novavax COVID-19 Vaccine in Great Britain* 2022-02-03 21:22
Phenomenex Celebrates 40-Years of Keeping Scientists Happy & What's to Come 2022-02-03 06:49
Avidien Technologies Receives $4M Investment from BroadOak Capital Partners 2022-02-02 18:49
CordenPharma Completes Acquisition of Three Manufacturing Facilities from Vifor Pharma 2022-02-02 11:00
World's most trusted source for chemistry information, CAS, launches major biology expansion 2022-02-02 10:42
New Business Partnership Between Otsuka Pharmaceutical and Digital Health VR Technology Developer Jolly Good 2022-02-01 21:00
AMR Action Fund Appoints Scientific Advisory Board 2022-02-01 19:00
Cytiva fuels biotech development in Australia and New Zealand 2022-02-01 07:00
DEBIOPHARM AND ASPEN PARTNER TO LAUNCH PROSTATE CANCER DRUG TRELSTAR® IN SOUTH AFRICA 2022-02-01 06:00
Denovo Biopharma LLC Announces FDA Approval of IND to Initiate First Biomarker-Guided Global CNS Clinical Trial for Treatment-Resistant Depression (TRD) 2022-02-01 05:30
Exopharm and Astellas Institute for Regenerative Medicine (AIRM) Sign Master Collaborative Services Agreement 2022-01-31 19:00
Pfizer and Alex Therapeutics announce a Strategic Commercial Partnership to provide evidence-based Digital Therapeutics to patients, starting in Germany 2022-01-31 18:00
AKESO'S LIGUFALIMAB AND IVONESCIMAB OBTAINED APPROVAL TO INITIATE A PHASE II TRIAL 2022-01-31 10:14
AKESO DOSES FIRST PATIENT IN THE PHASE III TRIAL OF IVONESCIMAB COMBINED WITH CHEMOTHERAPY IN EGFR-TKI RESISTANT EGFR MUTATION ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER 2022-01-31 09:51
HanBio Therapeutics Announces the Completion of a US$40 Million Series A Financing Led by OrbiMed and Hankang Capital 2022-01-29 11:37
1 182 183 184 185 186 440